A Power Prior Approach for Leveraging External Longitudinal and Competing Risks Survival Data Within the Joint Modeling Framework

Allocco DJ, Cannon LA, Britt A, Heil JE, Nersesov A, Wehrenberg S, Dawkins KD, Kereiakes DJ (2010) A prospective evaluation of the safety and efficacy of the taxus element paclitaxel-eluting coronary stent system for the treatment of de novo coronary artery lesions: design and statistical methods of the perseus clinical program. Trials 11(1):1 Ankerst DP, Hoefler J, Bock S, Goodman PJ, Vickers A, Hernandez J, Sokoll LJ, Sanda MG, Wei JT, Leach RJ et al (2014) Prostate cancer prevention trial risk calculator 2.0 for the prediction of low-vs high-grade prostate cancer. Urology 83(6):1362–1368 Barnard J, McCulloch R, Meng XL (2000) Modeling covariance matrices in terms of standard deviations and correlations, with application to shrinkage. Stat Sin, pp 1281–1311 Barrington WE, Schenk JM, Etzioni R, Arnold KB, Neuhouser ML, Thompson IM, Lucia MS, Kristal AR (2015) Difference in association of obesity with prostate cancer risk between us African American and non-Hispanic white men in the selenium and vitamin e cancer prevention trial (select). JAMA Oncol 1(3):342–349 Chen MH, Ibrahim JG, Lam P, Yu A, Zhang Y (2011) Bayesian design of noninferiority trials for medical devices using historical data. Biometrics 67(3):1163–1170 Chen MH, de Castro M, Ge M, Zhang Y (2013) Bayesian regression models for competing risks. In: Klein JP, van Houwelingen HC, Ibrahim JG, Scheike TH (eds) Handbook of survival analysis. Chapman & Hall/CRC, Boca Raton, pp 179–198 Chen MH, Ibrahim JG, Zeng D, Hu K, Jia C (2014) Bayesian design of superiority clinical trials for recurrent events data with applications to bleeding and transfusion events in myelodyplastic syndrome. Biometrics 70(4):1003–1013 Elashoff RM, Li G, Li N (2007) An approach to joint analysis of longitudinal measurements and competing risks failure time data. Stat Med 26(14):2813–2835 Ferrer L, Rondeau V, Dignam J, Pickles T, Jacqmin-Gadda H, Proust-Lima C (2016) Joint modelling of longitudinal and multi-state processes: application to clinical progressions in prostate cancer. Stat Med 35(22):3933–3948 Ghadessi M, Tang R, Zhou J, Liu R, Wang C, Toyoizumi K, Mei C, Zhang L, Deng C, Beckman RA (2020) A roadmap to using historical controls in clinical trials-by drug information association adaptive design scientific working group (dia-adswg). Orphanet J Rare Dis 15(1):1–19 Gilks WR, Wild P (1992) Adaptive rejection sampling for Gibbs sampling. J R Stat Soc 41(2):337–348 Hall KT, Vase L, Tobias DK, Dashti HT, Vollert J, Kaptchuk TJ, Cook NR (2020) Historical controls in randomized clinical trials: opportunities and challenges. Clin Pharmacol Therap Hastings WK (1970) Monte Carlo sampling methods using Markov chains and their applications. Biometrika 57:97–109 Hobbs BP, Carlin BP, Mandrekar SJ, Sargent DJ (2011) Hierarchical commensurate and power prior models for adaptive incorporation of historical information in clinical trials. Biometrics 67(3):1047–1056 Hobbs BP, Sargent DJ, Carlin BP (2012) Commensurate priors for incorporating historical information in clinical trials using general and generalized linear models. Bayesian Anal (Online) 7(3):639–674 Ibrahim JG, Chen MH et al (2000) Power prior distributions for regression models. Stat Sci 15(1):46–60 Ibrahim JG, Chen MH, Sinha D (2003) On optimality properties of the power prior. J Am Stat Assoc 98(461):204–213 Ibrahim JG, Chen MH, Xia HA, Liu T (2012) Bayesian meta-experimental design: evaluating cardiovascular risk in new antidiabetic therapies to treat type 2 diabetes. Biometrics 68(2):578–586 Ibrahim JG, Chen MH, Gwon Y, Chen F (2015) The power prior: theory and applications. Stat Med 34(28):3724–3749 Lewandowski D, Kurowicka D, Joe H (2009) Generating random correlation matrices based on vines and extended onion method. J Multivar Anal 100(9):1989–2001 Li N, Elashoff RM, Li G, Tseng CH (2012) Joint analysis of bivariate longitudinal ordinal outcomes and competing risks survival times with nonparametric distributions for random effects. Stat Med 31(16):1707–1721 Lim J, Walley R, Yuan J, Liu J, Dabral A, Best N, Grieve A, Hampson L, Wolfram J, Woodward P et al (2018) Minimizing patient burden through the use of historical subject-level data in innovative confirmatory clinical trials: review of methods and opportunities. Therap Innov Regul Sci 52(5):546–559 Metropolis N, Rosenbluth AW, Rosenbluth MN, Teller AH, Teller E (1953) Equation of state calculations by fast computing machines. J Chem Phys 21(6):1087–1092 Neuenschwander B, Roychoudhury S, Schmidli H (2016) On the use of co-data in clinical trials. Stat Biopharm Res 8(3):345–354 Schmidli H, Häring DA, Thomas M, Cassidy A, Weber S, Bretz F (2020) Beyond randomized clinical trials: use of external controls. Clin Pharmacol Therap 107(4):806–816 Shao K, Allen BC, Wheeler MW (2017) Bayesian hierarchical structure for quantifying population variability to inform probabilistic health risk assessments. Risk Anal 37(10):1865–1878 Sheikh MT, Ibrahim J, Gelfond JA, Sun W, Chen MH (2021) Joint modeling of longitudinal and survival data in the presence of competing risks with applications to prostate cancer data. Stat Model 21(1–2):72–94 Spiegelhalter DJ, Best NG, Carlin BP, Van Der Linde A (2002) Bayesian measures of model complexity and fit. J R Stat Soc 64(4):583–639 van Rosmalen J, Dejardin D, van Norden Y, Löwenberg B, Lesaffre E (2018) Including historical data in the analysis of clinical trials: is it worth the effort? Stat Methods Med Res 27(10):3167–3182 Viele K, Berry S, Neuenschwander B, Amzal B, Chen F, Enas N, Hobbs B, Ibrahim JG, Kinnersley N, Lindborg S et al (2014) Use of historical control data for assessing treatment effects in clinical trials. Pharm Stat 13(1):41–54 Williamson PR, Kolamunnage-Dona R, Philipson P, Marson AG (2008) Joint modelling of longitudinal and competing risks data. Stat Med 27(30):6426–6438. https://doi.org/10.1002/sim.3451 Yuan W, Chen MH, Zhong J (2020) Bayesian design of superiority trials: methods and applications. Tech. Rep. 20-37, Department of Statistics, University of Connecticut Zhang F, Chen MH, Cong XJ, Chen Q (2021) Assessing importance of biomarkers: a Bayesian joint modelling approach of longitudinal and survival data with semi-competing risks. Stat Model 21(1–2):30–55